Research progress of primary pulmonary lymphoepithelioma-like carcinoma / 国际肿瘤学杂志
Journal of International Oncology
; (12): 174-178, 2023.
Article
en Zh
| WPRIM
| ID: wpr-989540
Biblioteca responsable:
WPRO
ABSTRACT
Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a distinct type of lung cancer with histological profiles similar to nasopharyngeal carcinoma. The development is associated with EBV and plasma EBV DNA has predictive value in the progression and prognosis of PPLELC. PPLELC is different from some other types of lung cancer in that it has a low mutation rate of the classical lung cancer driver genes and targeted therapy is ineffective for it. Chemotherapy combined with immunotherapy may be the best first-line treatment option for patients with advanced PPLELC.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2023
Tipo del documento:
Article